Hospital Medicine

Roger M. Mills, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Roger M. Mills, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Roger M. Mills, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Roger M. Mills, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Roger M. Mills, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Roger M. Mills, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Hassan W. Nemeh, MD
Department of Thoracic and Cardiovascular Surgery, Loyola University Medical Center, Maywood, IL

Nicholas G. Smedira, MD
Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic

Address: Hassan W. Nemeh, MD, Loyola University Medical Center, 2160 South First Avenue, Building 110, Room 6237, Maywood, IL 60153; e-mail: [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Hassan W. Nemeh, MD
Department of Thoracic and Cardiovascular Surgery, Loyola University Medical Center, Maywood, IL

Nicholas G. Smedira, MD
Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic

Address: Hassan W. Nemeh, MD, Loyola University Medical Center, 2160 South First Avenue, Building 110, Room 6237, Maywood, IL 60153; e-mail: [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Hassan W. Nemeh, MD
Department of Thoracic and Cardiovascular Surgery, Loyola University Medical Center, Maywood, IL

Nicholas G. Smedira, MD
Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic

Address: Hassan W. Nemeh, MD, Loyola University Medical Center, 2160 South First Avenue, Building 110, Room 6237, Maywood, IL 60153; e-mail: [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

William C. Cook, DO
Department of Internal Medicine, The Cleveland Clinic

Jeffrey Chapman, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Jeffrey Chapman, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

William C. Cook, DO
Department of Internal Medicine, The Cleveland Clinic

Jeffrey Chapman, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Jeffrey Chapman, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

William C. Cook, DO
Department of Internal Medicine, The Cleveland Clinic

Jeffrey Chapman, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Jeffrey Chapman, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Teresa L. Carman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, and Head, Section of Hematology and Coagulation Medicine, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Teresa L. Carman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, and Head, Section of Hematology and Coagulation Medicine, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Teresa L. Carman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, and Head, Section of Hematology and Coagulation Medicine, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Joseph V. Nally, Jr., MD
Department of Nephrology and Hypertension, The Cleveland Clinic

Address: Joseph V. Nally, Jr., MD, Department of Nephrology and Hypertension, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Joseph V. Nally, Jr., MD
Department of Nephrology and Hypertension, The Cleveland Clinic

Address: Joseph V. Nally, Jr., MD, Department of Nephrology and Hypertension, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Joseph V. Nally, Jr., MD
Department of Nephrology and Hypertension, The Cleveland Clinic

Address: Joseph V. Nally, Jr., MD, Department of Nephrology and Hypertension, A51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.

Marianne Shaw, MD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Marianne Shaw, MD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Marianne Shaw, MD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Marianne Shaw, MD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Marianne Shaw, MD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Marianne Shaw, MD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Steven P. LaRosa, MD
Associate Staff Physician, Department of Infectious Diseases, Cleveland Clinic

Address: Steven P. LaRosa, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. LaRosa has indicated that he owns stock in Eli Lilly and Company.

Steven P. LaRosa, MD
Associate Staff Physician, Department of Infectious Diseases, Cleveland Clinic

Address: Steven P. LaRosa, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. LaRosa has indicated that he owns stock in Eli Lilly and Company.

Steven P. LaRosa, MD
Associate Staff Physician, Department of Infectious Diseases, Cleveland Clinic

Address: Steven P. LaRosa, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. LaRosa has indicated that he owns stock in Eli Lilly and Company.